Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.09
+0.13 (2.62%)
At close: Feb 27, 2026
-5.39%
Market Cap 23.05B
Revenue (ttm) 14.35B
Net Income (ttm) 2.16B
Shares Out 4.53B
EPS (ttm) 0.47
PE Ratio 10.80
Forward PE 9.62
Dividend 0.24 (4.72%)
Ex-Dividend Date Oct 21, 2025
Volume 22,874,060
Average Volume 15,279,987
Open 4.97
Previous Close 4.96
Day's Range 4.94 - 5.09
52-Week Range 4.82 - 7.39
Beta 0.20
RSI 45.58
Earnings Date Mar 26, 2026

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ... [Read more]

Sector Healthcare
Founded 1988
Employees 13,063
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1066
Full Company Profile

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.